SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-187483
Filing Date
2019-07-01
Accepted
2019-07-01 17:18:56
Documents
2
Period of Report
2019-06-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d736423d8k.htm 8-K 27677
2 EX-10.1 d736423dex101.htm EX-10.1 55477
  Complete submission text file 0001193125-19-187483.txt   84464
Mailing Address 44 WHIPPANY ROAD MORRISTOWN NJ 07963
Business Address 44 WHIPPANY ROAD MORRISTOWN NJ 07963 908 617-1309
MELINTA THERAPEUTICS, INC. /NEW/ (Filer) CIK: 0001461993 (see all company filings)

IRS No.: 454440364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35405 | Film No.: 19934217
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences